Efficacy of a 6-month versus 9-month intermittent treatment regimen in HIV-infected patients with tuberculosis: a randomized clinical trial
S Swaminathan, G Narendran… - American journal of …, 2010 - atsjournals.org
Rationale: The outcome of fully intermittent thrice-weekly antituberculosis treatment of
various durations in HIV-associated tuberculosis is unclear. Objectives: To compare the
efficacy of an intermittent 6-month regimen (Reg6M: 2EHRZ3/4HR3 [ethambutol, 1,200 mg;
isoniazid, 600 mg; rifampicin, 450 or 600 mg depending on body weight< 60 or≥ 60 kg; and
pyrazinamide, 1,500 mg for 2 mo; followed by 4 mo of isoniazid and rifampicin at the same
doses]) versus a 9-month regimen (Reg9M: 2EHRZ3/7HR3) in HIV/tuberculosis (TB) …
various durations in HIV-associated tuberculosis is unclear. Objectives: To compare the
efficacy of an intermittent 6-month regimen (Reg6M: 2EHRZ3/4HR3 [ethambutol, 1,200 mg;
isoniazid, 600 mg; rifampicin, 450 or 600 mg depending on body weight< 60 or≥ 60 kg; and
pyrazinamide, 1,500 mg for 2 mo; followed by 4 mo of isoniazid and rifampicin at the same
doses]) versus a 9-month regimen (Reg9M: 2EHRZ3/7HR3) in HIV/tuberculosis (TB) …
Efficacy of a 6-month versus 9-month intermittent treatment regimen in HIV-infected patients with tuberculosis a randomized clinical trial.
SS Soumya Swaminathan, GN Gopalan Narendran… - 2010 - cabidigitallibrary.org
Rationale: The outcome of fully intermittent thrice-weekly antituberculosis treatment of
various durations in HIV-associated tuberculosis is unclear. Objectives: To compare the
efficacy of an intermittent 6-month regimen (Reg6M: 2EHRZ3/4HR3 [ethambutol, 1,200 mg;
isoniazid, 600 mg; rifampicin, 450 or 600 mg depending on body weight< 60 or≥ 60 kg; and
pyrazinamide, 1,500 mg for 2 mo; followed by 4 mo of isoniazid and rifampicin at the same
doses]) versus a 9-month regimen (Reg9M: 2EHRZ3/7HR3) in HIV/tuberculosis (TB) …
various durations in HIV-associated tuberculosis is unclear. Objectives: To compare the
efficacy of an intermittent 6-month regimen (Reg6M: 2EHRZ3/4HR3 [ethambutol, 1,200 mg;
isoniazid, 600 mg; rifampicin, 450 or 600 mg depending on body weight< 60 or≥ 60 kg; and
pyrazinamide, 1,500 mg for 2 mo; followed by 4 mo of isoniazid and rifampicin at the same
doses]) versus a 9-month regimen (Reg9M: 2EHRZ3/7HR3) in HIV/tuberculosis (TB) …
以上显示的是最相近的搜索结果。 查看全部搜索结果